Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap USD M12.1Revenue USD M1.3Net Margin (%)-293.6Altman Z-Score-8.3
Enterprise Value USD M7.3EPS USD -1.3Operating Margin %-294.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-32.9Pre-tax Margin (%)-293.6Higher ROA y-yN
Price/Book0.610-y EBITDA Growth Rate %-38.9Quick Ratio5.6Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %-59.9Current Ratio5.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-32.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-36.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.8ROIC % (ttm)-61.0Gross Margin Increase y-yY

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ROSG is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

    More From Other Websites
    Rosetta Genomics to Present at Source Capital's 2016 Disruptive Growth & Healthcare Conference Feb 08 2016
    Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of... Feb 01 2016
    Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of... Feb 01 2016
    Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for... Jan 25 2016
    Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for... Jan 25 2016
    Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules for the Treatment of... Jan 11 2016
    CORRECTING and REPLACING Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules... Jan 11 2016
    Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the... Jan 06 2016
    Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the... Jan 06 2016
    Rosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald Rating Dec 18 2015
    4 Stocks Under $10 Showing Great Upside Today Dec 18 2015
    4 Biotech Stocks Under $10 Poised for Big Breakouts Dec 18 2015
    Coverage initiated on Rosetta Genomics by Cantor Fitzgerald Dec 18 2015
    Rosetta Genomics and Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA... Dec 14 2015
    Rosetta Genomics and Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA... Dec 14 2015
    Rosetta Genomics and Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA... Dec 14 2015
    Rosetta Genomics to Present at the LD Micro Main Event Dec 09 2015
    Rosetta Genomics Reports Third Quarter 2015 Financial Results Dec 09 2015
    ROSETTA GENOMICS LTD. Financials Dec 08 2015
    ROSG Reports Record Revenue for Third Quarter 2015 Dec 02 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK